Biocon Live BSE/NSE | Biocon Fundamenta data | Biocon Balance sheet | Biocon Quarterly Results | Biocon Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

53,736.00
77.73
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

55,362.80
N/A
7.94

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.43
13.72
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.97
10.36
8.68

PAT CAGR (%)

10 Years
5 Years
3 Years

7.78
8.01
30.32

P:E (Median)

8 Years
5 Years
3 Years

23.54
39.62
54.16

P:BV (Average)

8 Years
5 Years
3 Years

4.25
5.25
6.22

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.76
23.53
27.88

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 521 481 8% 482 463 4% 501 443 13% 524 457 15%
Expenses 404 407 -1% 439 420 4% 424 403 5% 434 395 10%
EBITDA 117 73 59% 43 42 2% 77 40 92% 90 61 46%
EBIDTM 8% 15% 9% 9% 15% 9% 17% 13%
Other Income 36 25 42% 67 13 417% 51 35 46% 60 46 32%
Interest 0 0 -80% 0 1 -67% 0 1 -88% 0 1 -67%
Depreciation 26 24 7% 25 23 5% 25 23 8% 24 23 4%
PBT 127 156 -19% 108 31 246% 158 51 210% 126 118 7%
Tax 42 34 23% 15 0 4867% 37 7 462% 26 18 47%
PAT 85 122 -30% 94 31 201% 121 44 172% 100 100 0%
PATM -2% 25% 19% 7% 24% 10% 19% 22%
EPS 0.71 1.02 -30% 0.78 0.26 200% 1.01 0.37 173% 0.83 0.83 0%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 1,671 1,466 14% 1,581 1,529 3% 1,748 1,541 13% 1,572 1,321 19%
Expenses 1,258 1,028 22% 1,262 1,126 12% 1,304 1,160 12% 1,169 981 19%
EBITDA 413 438 -6% 319 403 -21% 444 381 17% 403 340 19%
EBIDTM 25% 30% 14% 26% 25% 25% 26% 26%
Other Income 18 24 -24% 63 28 124% 36 26 40% 38 54 -29%
Interest 12 17 -25% 17 16 6% 18 19 -5% 14 19 -27%
Depreciation 167 124 34% 152 120 27% 144 117 23% 132 112 17%
PBT 252 321 -21% 212 296 -28% 318 277 15% 363 452 -20%
Tax 81 85 -5% 45 41 10% 85 46 84% 100 73 37%
PAT 171 236 -27% 168 255 -34% 234 231 1% 263 379 -30%
PATM 10% 16% 7% 17% 13% 15% 17% 29%
EPS 1.43 1.96 -27% 1.40 2.12 -34% 1.95 1.92 2% 2.19 3.16 -31%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 2,028 2,184 2,885 2,419 2,588 2,302 2,242 2,202 1,938 1,556 1,561 Net Sales Growth 10% -24% 19% -7% 12% 3% 2% 14% 25% 0% Cost Of Goods Sold 917 828 1,257 1,049 1,035 988 947 951 862 704 622 Gross Profit 1,111 1,356 1,628 1,370 1,553 1,314 1,294 1,252 1,076 851 939 GP Margin 55% 62% 56% 57% 60% 57% 58% 57% 56% 55% 60% Total Expenditure 1,701 1,889 2,499 2,101 1,996 1,880 1,812 1,729 1,536 1,224 1,015 Power & Fuel Cost - 193 202 161 146 155 165 162 142 98 82 % Of Sales - 9% 7% 7% 6% 7% 7% 7% 7% 6% 5% Employee Cost - 345 510 409 365 322 284 266 228 192 146 % Of Sales - 16% 18% 17% 14% 14% 13% 12% 12% 12% 9% Manufacturing Exp. - 225 309 292 221 202 196 128 115 67 43 % Of Sales - 10% 11% 12% 9% 9% 9% 6% 6% 4% 3% General & Admin Exp. - 256 103 96 89 104 96 93 82 69 55 % Of Sales - 12% 4% 4% 3% 5% 4% 4% 4% 4% 4% Selling & Distn. Exp. - 30 97 70 96 96 95 110 93 85 59 % Of Sales - 1% 3% 3% 4% 4% 4% 5% 5% 5% 4% Miscellaneous Exp. - 13 21 24 44 14 28 20 13 9 59 % Of Sales - 1% 1% 1% 2% 1% 1% 1% 1% 1% 1% EBITDA 327 295 386 318 592 422 430 473 402 332 546 EBITDA Margin 16% 14% 13% 13% 23% 18% 19% 21% 21% 21% 35% Other Income 215 205 118 125 99 173 149 61 56 69 63 Interest 1 1 3 1 4 2 1 1 1 2 1 Depreciation 100 98 147 136 151 140 128 124 95 94 90 PBT 519 400 353 306 536 453 450 409 361 304 517 Tax 120 119 59 67 17 191 67 84 71 49 58 Tax Rate 23% 21% 11% 22% 3% 34% 16% 21% 21% 16% 11% PAT 399 441 493 238 519 369 361 324 276 256 459 PAT before Minority Interest 399 441 493 238 519 369 361 324 276 256 459 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 20% 20% 17% 10% 20% 16% 16% 15% 14% 16% 29% PAT Growth 34% -11% 107% -54% 41% 2% 11% 18% 8% -44% EPS 3.33 3.67 4.11 1.99 4.33 3.07 3.01 2.70 2.30 2.13 3.83

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

2,028

2,184

2,885

2,419

2,588

2,302

2,242

2,202

1,938

1,556

1,561

Net Sales Growth

10%

-24%

19%

-7%

12%

14%

25%

Cost Of Goods Sold

917

828

1,257

1,049

1,035

988

947

951

862

704

622

Gross Profit

1,111

1,356

1,628

1,370

1,553

1,314

1,294

1,252

1,076

851

939

GP Margin

55%

62%

56%

57%

60%

57%

58%

57%

56%

55%

60%

Total Expenditure

1,701

1,889

2,499

2,101

1,996

1,880

1,812

1,729

1,536

1,224

1,015

Power & Fuel Cost

193

202

161

146

155

165

162

142

% Of Sales

Employee Cost

345

510

409

365

322

284

266

228

192

146

% Of Sales

16%

18%

17%

14%

13%

12%

Manufacturing Exp.

225

309

292

221

202

196

128

115

% Of Sales

10%

11%

12%

General & Admin Exp.

256

103

104

% Of Sales

12%

Selling & Distn. Exp.

110

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

327

295

386

318

592

422

430

473

402

332

546

EBITDA Margin

16%

14%

13%

23%

18%

19%

21%

35%

Other Income

215

205

118

125

173

149

Interest

Depreciation

100

147

136

151

140

128

124

PBT

519

400

353

306

536

453

450

409

361

304

517

Tax

120

119

191

Tax Rate

23%

21%

11%

22%

34%

16%

21%

16%

11%

PAT

399

441

493

238

519

369

361

324

276

256

459

PAT before Minority Interest

399

441

493

238

519

369

361

324

276

256

459

Minority Interest

PAT Margin

20%

17%

10%

20%

16%

15%

14%

16%

29%

PAT Growth

34%

-11%

107%

-54%

41%

11%

18%

-44%

EPS

3.33

3.67

4.11

1.99

4.33

3.07

3.01

2.70

2.30

2.13

3.83

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 6,573 6,367 5,514 4,123 3,891 3,347 3,090 2,877 2,485 2,086 1,806 Net Sales Growth 12% 15% 34% 6% 16% 8% 7% 16% 19% 16% Cost Of Goods Sold 6,241 2,052 1,897 1,636 1,447 1,290 1,256 1,186 1,044 852 725 Gross Profit 332 4,315 3,618 2,487 2,444 2,057 1,834 1,691 1,441 1,234 1,081 GP Margin 5% 68% 66% 60% 63% 61% 59% 59% 58% 59% 60% Total Expenditure 4,994 5,110 4,121 3,294 2,912 2,580 2,394 2,190 1,946 1,809 2,213 Power & Fuel Cost - 246 240 189 156 185 177 162 143 97 82 % Of Sales - 4% 4% 5% 4% 6% 6% 6% 6% 5% 5% Employee Cost - 1,459 1,165 931 747 610 533 466 389 308 239 % Of Sales - 23% 21% 23% 19% 18% 17% 16% 16% 15% 13% Manufacturing Exp. - 865 451 336 392 204 81 63 95 113 82 % Of Sales - 14% 8% 8% 10% 6% 3% 2% 4% 5% 5% General & Admin Exp. - 182 53 57 22 145 166 132 122 93 82 % Of Sales - 3% 1% 1% 1% 4% 5% 5% 5% 4% 5% Selling & Distn. Exp. - 270 278 98 107 101 109 119 100 89 62 % Of Sales - 4% 5% 2% 3% 3% 4% 4% 4% 4% 3% Miscellaneous Exp. - 36 37 47 41 45 73 62 53 257 62 % Of Sales - 1% 1% 1% 1% 1% 2% 2% 2% 12% 52% EBITDA 1,579 1,257 1,394 829 980 768 696 687 539 277 -407 EBITDA Margin 24% 20% 25% 20% 25% 23% 23% 24% 22% 13% -23% Other Income 156 508 144 206 157 79 53 56 57 309 1,036 Interest 61 65 71 62 26 29 9 2 8 12 24 Depreciation 595 552 448 385 277 249 221 204 179 176 157 PBT 1,146 1,147 1,019 589 833 569 519 538 408 398 447 Tax 311 315 212 157 162 142 96 107 98 56 72 Tax Rate 27% 26% 17% 27% 19% 19% 15% 20% 16% 14% 16% PAT 836 777 904 351 596 529 497 414 509 342 368 PAT before Minority Interest 752 900 1,002 432 672 587 528 431 513 342 375 Minority Interest -84 -123 -97 -81 -76 -59 -31 -17 -4 -1 -8 PAT Margin 13% 12% 16% 9% 15% 16% 16% 14% 20% 16% 20% PAT Growth -24% -14% 158% -41% 13% 6% 20% -19% 49% -7% EPS 6.96 6.48 7.54 2.93 4.97 4.41 4.15 3.45 4.24 2.85 3.06

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

6,573

6,367

5,514

4,123

3,891

3,347

3,090

2,877

2,485

2,086

1,806

Net Sales Growth

12%

15%

34%

16%

19%

16%

Cost Of Goods Sold

6,241

2,052

1,897

1,636

1,447

1,290

1,256

1,186

1,044

852

725

Gross Profit

332

4,315

3,618

2,487

2,444

2,057

1,834

1,691

1,441

1,234

1,081

GP Margin

68%

66%

60%

63%

61%

59%

58%

59%

60%

Total Expenditure

4,994

5,110

4,121

3,294

2,912

2,580

2,394

2,190

1,946

1,809

2,213

Power & Fuel Cost

246

240

189

156

185

177

162

143

% Of Sales

Employee Cost

1,459

1,165

931

747

610

533

466

389

308

239

% Of Sales

23%

21%

23%

19%

18%

17%

16%

15%

13%

Manufacturing Exp.

865

451

336

392

204

113

% Of Sales

14%

10%

General & Admin Exp.

182

145

166

132

122

% Of Sales

Selling & Distn. Exp.

270

278

107

101

109

119

100

% Of Sales

Miscellaneous Exp.

257

% Of Sales

12%

52%

EBITDA

1,579

1,257

1,394

829

980

768

696

687

539

277

-407

EBITDA Margin

24%

20%

25%

20%

25%

23%

24%

22%

13%

-23%

Other Income

156

508

144

206

157

309

1,036

Interest

Depreciation

595

552

448

385

277

249

221

204

179

176

157

PBT

1,146

1,147

1,019

589

833

569

519

538

408

398

447

Tax

311

315

212

157

162

142

107

Tax Rate

27%

26%

17%

27%

19%

15%

20%

16%

14%

16%

PAT

836

777

904

351

596

529

497

414

509

342

368

PAT before Minority Interest

752

900

1,002

432

672

587

528

431

513

342

375

Minority Interest

-84

-123

-97

-81

-76

-59

-31

-17

-4

-1

-8

PAT Margin

13%

12%

16%

15%

16%

14%

20%

16%

20%

PAT Growth

-24%

-14%

158%

-41%

13%

20%

-19%

49%

-7%

EPS

6.96

6.48

7.54

2.93

4.97

4.41

4.15

3.45

4.24

2.85

3.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 7,537 7,115 6,739 6,541 5,997 2,584 2,418 2,207 2,096 1,947 Share Capital 600 300 300 100 100 100 100 100 100 100 Total Reserves 6,854 6,756 6,389 6,397 5,897 2,458 2,203 2,004 1,904 1,764 Non-Current Liabilities -134 -70 54 117 239 185 197 178 160 176 Secured Loans -1 -1 64 128 125 0 0 0 0 0 Unsecured Loans 1 2 3 4 11 11 26 40 60 66 Long Term Provisions 21 25 17 13 10 0 0 0 0 1 Current Liabilities 728 993 832 705 863 564 604 628 564 482 Trade Payables 521 644 580 450 394 301 268 265 251 200 Other Current Liabilities 98 214 146 145 141 60 90 68 77 57 Short Term Borrowings 0 0 0 0 226 56 82 77 87 96 Short Term Provisions 109 135 106 110 101 147 164 218 149 129 Total Liabilities 8,131 8,038 7,625 7,364 7,098 3,333 3,218 3,013 2,820 2,604 Net Block 721 1,059 859 894 894 914 949 851 685 680 Gross Block 1,885 2,526 2,182 2,082 1,934 1,832 1,730 1,458 1,213 1,117 Accumulated Depreciation 1,164 1,467 1,323 1,188 1,040 918 781 606 528 438 Non Current Assets 6,048 5,592 5,567 4,985 4,727 1,597 1,751 1,540 1,468 1,292 Capital Work in Progress 152 254 318 241 172 58 102 51 82 103 Non Current Investment 4,886 3,945 3,789 3,407 3,254 80 145 166 166 92 Long Term Loans & Adv. 281 323 559 403 372 426 313 355 531 417 Other Non Current Assets 8 11 42 40 35 119 242 116 4 0 Current Assets 2,084 2,446 2,058 2,378 2,371 1,736 1,467 1,473 1,352 1,313 Current Investments 139 113 454 525 598 84 348 453 491 394 Inventories 535 802 562 540 505 406 358 359 340 275 Sundry Debtors 573 902 740 798 504 555 495 427 445 418 Cash & Bank 375 356 197 383 643 621 204 179 40 210 Other Current Assets 462 159 89 119 121 69 63 55 36 16 Short Term Loans & Adv. 172 114 16 14 75 50 57 51 29 14 Net Current Assets 1,356 1,453 1,226 1,673 1,508 1,172 864 845 788 831 Total Assets 8,131 8,038 7,625 7,364 7,098 3,333 3,218 3,013 2,820 2,604

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

7,537

7,115

6,739

6,541

5,997

2,584

2,418

2,207

2,096

1,947

Share Capital

600

300

100

Total Reserves

6,854

6,756

6,389

6,397

5,897

2,458

2,203

2,004

1,904

1,764

Non-Current Liabilities

-134

-70

117

239

185

197

178

160

176

Secured Loans

-1

128

125

Unsecured Loans

Long Term Provisions

Current Liabilities

728

993

832

705

863

564

604

628

564

482

Trade Payables

521

644

580

450

394

301

268

265

251

200

Other Current Liabilities

214

146

145

141

Short Term Borrowings

226

Short Term Provisions

109

135

106

110

101

147

164

218

149

129

Total Liabilities

8,131

8,038

7,625

7,364

7,098

3,333

3,218

3,013

2,820

2,604

Net Block

721

1,059

859

894

914

949

851

685

680

Gross Block

1,885

2,526

2,182

2,082

1,934

1,832

1,730

1,458

1,213

1,117

Accumulated Depreciation

1,164

1,467

1,323

1,188

1,040

918

781

606

528

438

Non Current Assets

6,048

5,592

5,567

4,985

4,727

1,597

1,751

1,540

1,468

1,292

Capital Work in Progress

152

254

318

241

172

102

103

Non Current Investment

4,886

3,945

3,789

3,407

3,254

145

166

Long Term Loans & Adv.

281

323

559

403

372

426

313

355

531

417

Other Non Current Assets

119

242

116

Current Assets

2,084

2,446

2,058

2,378

2,371

1,736

1,467

1,473

1,352

1,313

Current Investments

139

113

454

525

598

348

453

491

394

Inventories

535

802

562

540

505

406

358

359

340

275

Sundry Debtors

573

902

740

798

504

555

495

427

445

418

Cash & Bank

375

356

197

383

643

621

204

179

210

Other Current Assets

462

159

119

121

Short Term Loans & Adv.

172

114

Net Current Assets

1,356

1,453

1,226

1,673

1,508

1,172

864

845

788

831

Total Assets

8,131

8,038

7,625

7,364

7,098

3,333

3,218

3,013

2,820

2,604

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 6,706 6,098 5,181 4,838 4,034 3,271 3,027 2,695 2,272 2,033 Share Capital 600 300 300 100 100 100 100 100 100 100 Total Reserves 5,997 5,721 4,812 4,670 3,934 3,133 2,806 2,492 2,080 1,850 Non-Current Liabilities 2,685 2,123 2,006 2,305 2,421 1,378 1,262 666 645 456 Secured Loans 1,221 1,540 1,787 2,104 2,061 758 580 124 9 0 Unsecured Loans 1 2 3 4 11 11 26 40 60 66 Long Term Provisions 86 66 49 36 30 15 8 4 0 1 Current Liabilities 4,008 3,038 2,141 1,678 1,666 1,555 1,380 990 1,016 1,061 Trade Payables 1,325 1,198 1,005 740 610 429 347 346 348 296 Other Current Liabilities 1,784 1,374 870 698 527 706 612 313 269 376 Short Term Borrowings 668 261 130 97 395 261 244 85 187 247 Short Term Provisions 231 204 136 143 134 158 177 246 212 141 Total Liabilities 14,076 11,868 9,796 9,197 8,387 6,375 5,751 4,416 3,937 3,587 Net Block 5,971 4,471 3,700 3,625 1,748 1,630 1,525 1,510 1,270 1,316 Gross Block 9,147 7,095 5,874 5,436 3,404 3,034 2,702 2,481 2,066 1,966 Accumulated Depreciation 3,176 2,624 2,174 1,811 1,655 1,404 1,176 971 796 650 Non Current Assets 8,751 7,045 5,648 5,149 4,416 3,813 3,112 2,176 1,938 1,779 Capital Work in Progress 2,196 1,899 1,303 839 2,240 1,676 1,206 312 390 262 Non Current Investment 108 182 64 189 27 0 64 64 64 61 Long Term Loans & Adv. 402 402 437 320 350 337 252 242 181 140 Other Non Current Assets 73 91 144 176 51 170 64 47 32 0 Current Assets 5,325 4,823 4,149 4,048 3,971 2,563 2,639 2,240 2,000 1,807 Current Investments 858 829 611 1,065 875 230 700 522 492 400 Inventories 1,436 1,032 722 635 542 453 377 398 378 414 Sundry Debtors 1,224 1,292 1,064 883 714 770 600 510 492 496 Cash & Bank 999 1,057 1,323 1,044 1,539 938 804 673 523 442 Other Current Assets 809 566 373 396 301 172 158 137 114 57 Short Term Loans & Adv. 266 46 55 24 227 76 82 81 37 20 Net Current Assets 1,317 1,785 2,007 2,369 2,305 1,008 1,259 1,250 984 747 Total Assets 14,076 11,868 9,796 9,197 8,387 6,375 5,751 4,416 3,937 3,587

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

6,706

6,098

5,181

4,838

4,034

3,271

3,027

2,695

2,272

2,033

Share Capital

600

300

100

Total Reserves

5,997

5,721

4,812

4,670

3,934

3,133

2,806

2,492

2,080

1,850

Non-Current Liabilities

2,685

2,123

2,006

2,305

2,421

1,378

1,262

666

645

456

Secured Loans

1,221

1,540

1,787

2,104

2,061

758

580

124

Unsecured Loans

Long Term Provisions

Current Liabilities

4,008

3,038

2,141

1,678

1,666

1,555

1,380

990

1,016

1,061

Trade Payables

1,325

1,198

1,005

740

610

429

347

346

348

296

Other Current Liabilities

1,784

1,374

870

698

527

706

612

313

269

376

Short Term Borrowings

668

261

130

395

261

244

187

247

Short Term Provisions

231

204

136

143

134

158

177

246

212

141

Total Liabilities

14,076

11,868

9,796

9,197

8,387

6,375

5,751

4,416

3,937

3,587

Net Block

5,971

4,471

3,700

3,625

1,748

1,630

1,525

1,510

1,270

1,316

Gross Block

9,147

7,095

5,874

5,436

3,404

3,034

2,702

2,481

2,066

1,966

Accumulated Depreciation

3,176

2,624

2,174

1,811

1,655

1,404

1,176

971

796

650

Non Current Assets

8,751

7,045

5,648

5,149

4,416

3,813

3,112

2,176

1,938

1,779

Capital Work in Progress

2,196

1,899

1,303

839

2,240

1,676

1,206

312

390

262

Non Current Investment

108

182

189

Long Term Loans & Adv.

402

437

320

350

337

252

242

181

140

Other Non Current Assets

144

176

170

Current Assets

5,325

4,823

4,149

4,048

3,971

2,563

2,639

2,240

2,000

1,807

Current Investments

858

829

611

1,065

875

230

700

522

492

400

Inventories

1,436

1,032

722

635

542

453

377

398

378

414

Sundry Debtors

1,224

1,292

1,064

883

714

770

600

510

492

496

Cash & Bank

999

1,057

1,323

1,044

1,539

938

804

673

523

442

Other Current Assets

809

566

373

396

301

172

158

137

114

Short Term Loans & Adv.

266

227

Net Current Assets

1,317

1,785

2,007

2,369

2,305

1,008

1,259

1,250

984

747

Total Assets

14,076

11,868

9,796

9,197

8,387

6,375

5,751

4,416

3,937

3,587

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 387 110 355 186 208 125 186 348 160 355 PBT 560 552 306 536 559 428 409 347 304 517 Adjustment -68 -112 65 111 -88 4 80 69 57 54 Changes in Working Capital -14 -194 72 -340 -58 -224 -210 3 -143 -165 Cash after chg. in Working capital 478 246 443 306 414 208 279 419 219 406 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -91 -137 -88 -121 -205 -83 -93 -71 -58 -51 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -213 311 -556 110 -321 146 46 -87 -196 -150 Net Fixed Assets 744 -281 -178 -216 -217 -58 -323 -214 -75 -135 Net Investments -967 185 -311 -79 -3,688 328 126 38 -171 -67 Others 10 407 -67 406 3,584 -124 243 89 50 52 Cash from Financing Activity -129 -208 -55 -238 73 -158 -187 -147 -111 -100 Net Cash Inflow / Outflow 45 212 -255 58 -40 113 45 114 -147 104 Opening Cash & Equivalents 306 89 342 290 322 204 154 40 185 77 Closing Cash & Equivalent 375 306 89 342 290 316 204 154 40 185

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

387

110

355

186

208

125

186

348

160

355

PBT

560

552

306

536

559

428

409

347

304

517

Adjustment

-68

-112

111

-88

Changes in Working Capital

-14

-194

-340

-58

-224

-210

-143

-165

Cash after chg. in Working capital

478

246

443

306

414

208

279

419

219

406

Interest Paid

Tax Paid

-91

-137

-88

-121

-205

-83

-93

-71

-58

-51

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-213

311

-556

110

-321

146

-87

-196

-150

Net Fixed Assets

744

-281

-178

-216

-217

-58

-323

-214

-75

-135

Net Investments

-967

185

-311

-79

-3,688

328

126

-171

-67

Others

407

-67

406

3,584

-124

243

Cash from Financing Activity

-129

-208

-55

-238

-158

-187

-147

-111

-100

Net Cash Inflow / Outflow

212

-255

-40

113

114

-147

104

Opening Cash & Equivalents

306

342

290

322

204

154

185

Closing Cash & Equivalent

375

306

342

290

316

204

154

185

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 1,283 1,155 662 640 371 211 561 471 564 798 PBT 871 1,215 610 850 751 624 538 610 395 447 Adjustment 921 260 356 204 42 74 134 147 145 164 Changes in Working Capital -165 -29 -106 -211 -176 -354 38 -192 98 269 Cash after chg. in Working capital 1,627 1,446 859 843 617 344 709 565 638 880 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -344 -292 -197 -203 -246 -133 -149 -94 -74 -81 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -1,559 -714 -684 -498 -1,142 -509 -938 -376 -360 -314 Net Fixed Assets 744 -281 -178 -216 -217 -58 -323 -214 -75 -135 Net Investments -967 185 -311 -79 -3,688 328 126 38 -171 -67 Others -1,336 -618 -195 -203 2,763 -779 -741 -200 -113 -112 Cash from Financing Activity 388 -242 -240 -178 1,068 186 426 -9 -186 -275 Net Cash Inflow / Outflow 112 199 -262 -36 296 -112 49 87 18 209 Opening Cash & Equivalents 659 449 710 758 458 557 474 369 359 140 Closing Cash & Equivalent 825 659 449 710 758 463 557 474 369 359

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

1,283

1,155

662

640

371

211

561

471

564

798

PBT

871

1,215

610

850

751

624

538

610

395

447

Adjustment

921

260

356

204

134

147

145

164

Changes in Working Capital

-165

-29

-106

-211

-176

-354

-192

269

Cash after chg. in Working capital

1,627

1,446

859

843

617

344

709

565

638

880

Interest Paid

Tax Paid

-344

-292

-197

-203

-246

-133

-149

-94

-74

-81

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-1,559

-714

-684

-498

-1,142

-509

-938

-376

-360

-314

Net Fixed Assets

744

-281

-178

-216

-217

-58

-323

-214

-75

-135

Net Investments

-967

185

-311

-79

-3,688

328

126

-171

-67

Others

-1,336

-618

-195

-203

2,763

-779

-741

-200

-113

-112

Cash from Financing Activity

388

-242

-240

-178

1,068

186

426

-9

-186

-275

Net Cash Inflow / Outflow

112

199

-262

-36

296

-112

209

Opening Cash & Equivalents

659

449

710

758

458

557

474

369

359

140

Closing Cash & Equivalent

825

659

449

710

758

463

557

474

369

359

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 62 59 56 54 50 21 19 18 17 16 ROA 5% 6% 3% 7% 7% 11% 10% 9% 9% 19% ROE 6% 7% 4% 8% 9% 15% 15% 13% 13% 27% ROCE 8% 8% 5% 8% 12% 16% 17% 15% 14% 27% Fixed Asset Turnover 0.99 1.23 1.14 1.30 1.24 1.28 1.40 1.49 1.38 1.49 Receivable days 123 104 116 91 83 84 75 80 98 91 Inventory Days 112 86 83 73 71 61 58 64 70 59 Payable days 117 86 88 78 66 56 54 62 64 66 Cash Conversion Cycle 118 104 110 85 88 90 79 83 104 85 Total Debt/Equity 0.00 0.01 0.02 0.02 0.06 0.03 0.05 0.06 0.08 0.09 Interest Cover 468 213 307 142 295 536 455 290 180 518

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

11%

10%

19%

ROE

15%

13%

27%

ROCE

12%

16%

17%

15%

14%

27%

Fixed Asset Turnover

0.99

1.23

1.14

1.30

1.24

1.28

1.40

1.49

1.38

1.49

Receivable days

123

104

116

Inventory Days

112

Payable days

117

Cash Conversion Cycle

118

104

110

104

Total Debt/Equity

0.00

0.01

0.02

0.06

0.03

0.05

0.06

0.08

0.09

Interest Cover

468

213

307

142

295

536

455

290

180

518

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 55 50 43 40 34 27 24 22 18 16 ROA 7% 9% 5% 8% 8% 9% 8% 12% 9% 12% ROE 14% 18% 9% 15% 16% 17% 16% 22% 17% 21% ROCE 14% 16% 9% 13% 14% 15% 16% 22% 17% 20% Fixed Asset Turnover 0.78 0.85 0.73 0.89 1.05 1.09 1.12 1.11 1.06 0.97 Receivable days 72 78 86 74 80 80 69 72 84 93 Inventory Days 71 58 60 55 54 48 49 56 68 78 Payable days 81 87 88 79 71 58 56 65 70 71 Cash Conversion Cycle 62 49 58 50 63 70 62 63 82 100 Total Debt/Equity 0.40 0.40 0.44 0.48 0.61 0.35 0.30 0.10 0.12 0.17 Interest Cover 20 18 11 33 26 71 317 76 33 19

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

12%

ROE

14%

18%

15%

16%

17%

16%

22%

17%

21%

ROCE

14%

16%

13%

14%

15%

16%

22%

17%

20%

Fixed Asset Turnover

0.78

0.85

0.73

0.89

1.05

1.09

1.12

1.11

1.06

0.97

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

100

Total Debt/Equity

0.40

0.44

0.48

0.61

0.35

0.30

0.10

0.12

0.17

Interest Cover

317

Biocon Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532523 | NSE: BIOCON

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Biocon Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532523 | NSE: BIOCON

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update